info@doclabinc.com

(503) 402-2504

FDA Regulatory Consulting

From initial strategy through submission and FDA interaction, our regulatory specialists provide the expertise to navigate the FDA clearance process efficiently and effectively.

Companies We Serve

Medical Device Startups: Early-stage companies bringing first products to market. We help you understand the pathway, prepare properly, and avoid costly mistakes.

Established Manufacturers: Companies with existing portfolios adding new products or new indications. We provide specialized support for specific submissions.

Diagnostic Companies: In vitro diagnostic (IVD) manufacturers navigating FDA requirements for new diagnostic products.

International Companies: Companies seeking FDA clearance for products already marketed outside the United States.

Navigating FDA Requirements

Bringing a medical device or diagnostic to market requires FDA clearance—a process that can be complex, time-consuming, and costly if not approached correctly. The regulatory pathway isn’t always obvious, submission requirements are detailed, and FDA interactions require careful preparation.

For companies without deep regulatory experience, the FDA process can delay time-to-market, consume resources, and create frustration. Even experienced teams benefit from specialized guidance when navigating complex submissions.

Regulatory Expertise That Delivers Results

Our FDA consulting team brings hands-on experience with 510(k) and De Novo submissions across diagnostic and medical device categories. We understand FDA expectations, know how to prepare submissions that address reviewer concerns, and can help you navigate interactions with the agency effectively.

We take a practical, results-oriented approach. Our goal is efficient clearance—not endless consulting hours. We’ll be direct about what your submission needs, where risks lie, and how to address them.

What We Provide

Regulatory Strategy

  • Pathway determination (510(k), De Novo, or other)
  • Predicate device identification and analysis
  • Submission timeline planning
  • Risk assessment and mitigation strategies

510(k) Preparation

  • Submission planning and organization
  • Substantial equivalence arguments
  • Performance testing guidance
  • Labeling and IFU review
  • Complete submission package preparation

De Novo Preparation

  • De Novo request strategy
  • Classification recommendation development
  • Special controls identification
  • Risk-benefit analysis
  • Submission package preparation

FDA Interactions

  • Pre-submission (Q-Sub) meeting preparation
  • Meeting request and briefing document development
  • FDA communication strategy
  • Response preparation for FDA questions

Post-Submission Support

  • Response to Additional Information requests
  • Interactive review support
  • Clearance follow-through

Why Choose Doc Lab for FDA Consulting

R

Diagnostic Expertise

As a diagnostic manufacturer ourselves, we understand IVD regulatory requirements from the inside. Our experience goes beyond consulting—we've been through the process with our own products.

R

Practical Approach

We focus on what moves your submission forward efficiently. No unnecessary complexity, no padding hours—just practical guidance toward clearance.

R

Regulatory Depth

Our team includes specialists with extensive FDA regulatory experience across medical device and diagnostic categories.

R

Transparent Engagement

As a diagnostic manufacturer ourselves, we understand IVD regulatory requirements from the inside. Our experience goes beyond consulting—we've been through the process with our own products.

Common Questions